Allo-HSCT Might Improve Long-Term Survival in Patients with CD56-Positive AML

Journal of Blood Medicine · Published 2026-08-01 · DOI 10.2147/jbm.s602123

Free full text

Authors (13)

Xiaotong Zhu, Yuting Sun, Yanyan Chen, Raj Singh Dhurel, Chen Zhang, Yutong Xie, Man Ni, Wei Chen, Huanxin Zhang, Qingyun Wu, Depeng Li, Bin Pan, Zhiling Yan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhu, X., Sun, Y., Chen, Y., et al. (2026). Allo-HSCT Might Improve Long-Term Survival in Patients with CD56-Positive AML. Journal of Blood Medicine. https://doi.org/10.2147/jbm.s602123

Related articles